Impact of HIV and antiretroviral initiation on skeletal biology

HIV 和抗逆转录病毒治疗对骨骼生物学的影响

基本信息

项目摘要

ABSTRACT Osteoporosis and fractures are known complications of HIV and antiretroviral therapy (ART) but the mechanisms of HIV and ART associated bone loss are still uncertain because tissue-level data are lacking. In the parent grant (R21TW012367), we are performing a comprehensive longitudinal study to compare the skeletal effects of the two ART regimens (TDF/lamivudine/efavirenz and lamivudine/dolutegravir). We will evaluate bone density and strength using dual energy Xray absorptiometry (DXA) and High Resolution peripheral Quantitative CT (HRpQCT) with finite element analysis (Aim 1), obtain paired iliac-crest bone biopsies to evaluate histomorphometry and tissue-level mechanical properties using nanoindentation/ramen spectroscopy (Aim 2), and perform bone cell transcriptomics to explore underpinning molecular pathways. As PWH age, renal impairment is likely to increase as well as frequency of fracture. An association between proteinuria and osteoporosis/fracture has been recognized in people with and without HIV, although the mechanistic underpinnings of urinary loss of protein and bone fragility has not been established. Specific antiretrovirals, such as TDF cause proximal tubular dysfunction resulting in proteinuria but the effect of other co-morbidities and traditional factors also contribute. This administrative supplement offers a unique opportunity to study the role of proteinuria in bone loss among PWH in Brazil. Building upon the multidisciplinary collaboration of HIV and bone researchers from the U.S. and the University of São Paulo established in the parent grant, this supplement will provide additional opportunities for research and capacity building for aging-related research focusing on the kidney-bone axis
摘要 骨质疏松症和骨折是艾滋病毒和抗逆转录病毒治疗(ART)的已知并发症,但其机制 由于缺乏组织水平的数据,艾滋病毒和ART相关的骨质流失仍不确定。在父母补助金中 (R21 TW 012367),我们正在进行一项全面的纵向研究,以比较 两种ART方案(TDF/拉米夫定/依法韦仑和拉米夫定/度鲁特韦)。我们将评估骨密度, 使用双能X线吸收测定法(DXA)和高分辨率外周定量CT进行强度检查 (HRpQCT)与有限元分析(目的1),获得配对髂嵴骨活检,以评估 使用纳米压痕/拉曼光谱法进行组织形态测量和组织水平机械性能(目标2), 并进行骨细胞转录组学以探索基础分子途径。随着威尔斯亲王年龄的增长, 损伤可能增加,骨折频率也可能增加。蛋白尿与 骨质疏松症/骨折已被确认在有和没有艾滋病毒的人,虽然机制, 尿蛋白流失和骨脆性的基础尚未建立。特异性抗逆转录病毒药物,如 由于TDF引起近端肾小管功能障碍,导致蛋白尿,但其他合并症的影响, 传统因素也有影响。这一行政补充提供了一个独特的机会,研究的作用, 蛋白尿在巴西PWH骨质流失中的作用。基于HIV和骨的多学科合作 来自美国的研究人员.和圣保罗大学建立在家长补助金,这种补充将 提供更多的机会,进行与老龄化有关的研究和能力建设,重点是 肾骨轴

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rosa Maria Affonso Moyses其他文献

Rosa Maria Affonso Moyses的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rosa Maria Affonso Moyses', 18)}}的其他基金

Impact of HIV and antiretroviral initiation on skeletal biology
HIV 和抗逆转录病毒治疗对骨骼生物学的影响
  • 批准号:
    10657701
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Impact of HIV and antiretroviral initiation on skeletal biology
HIV 和抗逆转录病毒治疗对骨骼生物学的影响
  • 批准号:
    10537735
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了